Mineralys Therapeutics Inc
NASDAQ:MLYS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mineralys Therapeutics Inc
NASDAQ:MLYS
|
US |
Intrinsic Value
The intrinsic value of one MLYS stock under the Base Case scenario is 15.02 USD. Compared to the current market price of 27.17 USD, Mineralys Therapeutics Inc is Overvalued by 45%.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Mineralys Therapeutics Inc.
The intrinsic value of one MLYS stock under the Base Case scenario is 15.02 USD.
Compared to the current market price of 27.17 USD, Mineralys Therapeutics Inc is Overvalued by 45%.